483
Nippon Shikizai, Inc.Nippon Shikizai, Inc. – FDA 483, Sep 12, 2025
Record Details
Nippo Shikizai, Inc., a contract manufacturer of OTC drug products in Tsukuba, Japan, received six observations during an FDA inspection. The findings indicate significant deficiencies in cleaning validation, OOS investigations, component identity testing, equipment log maintenance, process validation, and the stability program. One observation regarding cleaning validation was a repeat from a previous inspection, highlighting persistent issues.
View Company Profile
ID · 69fbf760-09df-4a65-a799-7ba75f4da67f
Other documents for Nippon Shikizai, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.